From: Clinicobacteriological study of chronic dacryocystitis in Egypt
Antibiotic tested | CAF | CL | CAZ | CTX | CN | AK | TOB | GAT | CIP | LEV |
---|---|---|---|---|---|---|---|---|---|---|
Name of organism | ||||||||||
Staphylococcus aureus | 3/3 (100%) | 2/3 (66.6%) | 2/3 (66.6%) | 2/3 (66.6%) | 2/3 (66.6%) | 2/3 (66.6%) | 2/3 (66.6%) | 3/3 (100%) | 2/3 (66.6%) | 2/3 (66.6%) |
Staphylococcus epidermidis | 3/4 (75%) | 2/4 (50%) | 3/4 (75%) | 3/4 (75%) | ¾ (75%) | 4/4 (100%) | 4/4 (100%) | 4/4 (100%) | 3/4 (75%) | 3/4 (75%) |
Streptococcus pneumonia | 2/4 (5o %) | 3/4 (75%) | 2/4 (50%) | 2/4 (50%) | 2/4 (50%) | 3/4 (75%) | 2/4 (50%) | 3/4 (75%) | 2/4 (50%) | 2/4 (50%) |
Streptococcus Viridans | 1/1 (100%) | 0/1 (0%) | 1/1 (100%) | 1/1 (100%) | 1/1(100%) | 1/1 (100%) | 1/1 (100%) | 1/1 (100%) | 1/1 (100%) | 1/1 (100%) |
Total Gram-positive | 9/12 (75%) | 7/12 (58%) | 8/12 (66.6%) | 8/12 (66.6%) | 8/12 (66.6%) | 10/12 (83.3%) | 9/12 (75%) | 11/12 (91.6%) | 8/12 (66.6%) | 8/12 (66.6%) |
Klebsiella | 1/3 (33.3%) | 1/3 (33.3%) | 1/3 (33.3%) | 2/3 (66.6%) | 2/3 (66.6%) | 3/3 (100%) | 2/3 (66.6%) | 2/3 (66.6%) | 2/3 (66.6%) | 2/3 (66.6%) |
Pseudomonas | 1/2 (50%) | 1/2 (50%) | 2/2 (100%) | 2/2 (100%) | 1/2 (50%) | 2/2 (100%) | 1/2 (50%) | 2/2 (100%) | 1/2 (50%) | 1/2 (50%) |
Total Gram-negative | 2/5 (40%) | 2/5 (40%) | 3/5 (60%) | 4/5 (80%) | 3/5 (60%) | 5/5 (100%) | 3/5 (60%) | 4/5 (80%) | 3/5 (60%) | 3/5 (60%) |
Total | 11/17 (65%) | 9/17 (53%) | 11/17 (65%) | 12/17 (70.5%) | 11/17 (65%) | 15/17 (88.8%) | 12/17 (70.5%) | 15/17 (88.8%) | 11/17 (65%) | 11/17 (65%) |